NMP-based Bioimplants (Particulates, Strips, Fibers)

About Induce Biologics

Induce Biologics, founded in 2015, is a private, commercial-stage company focused on advancing bone regeneration through its proprietary NMP technology. The platform processes demineralized bone matrix to enhance the bioavailability of inherent growth factors, positioning its products as a potentially more natural and effective alternative to traditional bone grafts and synthetic biologics. With a seasoned leadership team boasting decades of experience in orthobiologics, the company is commercializing its product family in the substantial bone graft substitute market. Its key challenge lies in gaining market share against established competitors and demonstrating superior clinical outcomes.

Therapeutic Areas